Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXTJ2K
|
||||
Drug Name |
4-(5-{[[1-(3-Chloro-benzyl)-2-oxo-pyrrolidin-3-yl]-(2-piperazin-1-yl-ethyl)-amino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL101788
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H34ClN7O
|
||||
Canonical SMILES |
Clc1cccc(CN2CC[C@H](N(CCN3CCNCC3)Cc4cncn4Cc5ccc(cc5)C#N)C2=O)c1
|
||||
InChI |
InChI=1S/C29H34ClN7O/c30-26-3-1-2-25(16-26)20-36-11-8-28(29(36)38)35(15-14-34-12-9-32-10-13-34)21-27-18-33-22-37(27)19-24-6-4-23(17-31)5-7-24/h1-7,16,18,22,28,32H,8-15,19-21H2/t28-/m0/s1
|
||||
InChIKey |
OAOZPXOXMVMQBZ-NDEPHWFRSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.